vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 698-706

  Salata, Cristiano ^a   Curtarello, Matteo ^a   Calistri, Arianna ^a   Sartori, Elena ^a   Sette, Paola ^a   De Bernard, Marina ^a,b   Parolin, Cristina ^a   Palù, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VOX2 PROTEIN; AUTACOID; CD200R1 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; CYTOKINE; HLA ANTIGEN; INTERLEUKIN 1ALPHA; MEMBRANE ANTIGEN; MESSENGER RNA; PRIMER DNA; VIRUS RNA; VOX2 PROTEIN, KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS; VOX2 PROTEIN, KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS;

ARTICLE; CELL ACTIVITY; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MACROPHAGE; MACROPHAGE ACTIVATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL CULTURE; CELL LINE; COCULTURE; GENETIC TRANSDUCTION; GENETICS; HUMAN HERPESVIRUS 8; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOGENICITY; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

ANTIGENS, SURFACE; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DNA PRIMERS; HERPESVIRUS 8, HUMAN; HLA ANTIGENS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1ALPHA; MACROPHAGE ACTIVATION; MACROPHAGES; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; RNA, VIRAL; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 64549118705     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21722     Document Type: Article

References (48)

1. Anand RJ, Gribar SC, Li J, Kohler JW, Branca MF, Dubowski T, Sodhi CP, Hackam DJ. 2007. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner. J Leukoc Biol 82:1257-1265. (Pubitemid 350133524)
2. Antoniou AN, Powis SJ. 2008. Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Immunology 124:1-12.
3. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Stürzl M. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 71:7963-7968. (Pubitemid 27391749)
4. Brodsky FM, Lem L, Solache A, Bennett EM. 1999. Human pathogen subversion of antigen presentation. Immunol Rev 168:199-215. (Pubitemid 29276684)
5. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
6. Chung YH, Means RE, Choi JK, Lee BS, Jung JU. 2002. Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol 76:4688-4698. (Pubitemid 34441675)
7. Cirone M, Lucania G, Bergamo P, Trivedi P, Frati L, Faggioni A. 2007. Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity. Immunol Lett 113:40-46. (Pubitemid 47464619)
8. Clark MJ, Gagnon J, Williams AF, Barclay AN. 1985. MRC OX-2 antigen: A lymphoid/neuronal membrane glycoprotein with a structure like a single immunoglobulin light chain. EMBO J 4:113-118.
9. Coscoy L. 2007. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat Rev Immunol 7:391-401. (Pubitemid 46674490)
10. Deng JH, Zhang YJ, Wang XP, Gao SJ. 2004. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: Potential role in infection and malignant transformation. J Virol 78:11108-11120. (Pubitemid 39299651)
11. Du MQ, Bacon CM, Isaacson PG. 2007. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol 60:1350-1357. (Pubitemid 350247250)
12. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-8471. (Pubitemid 28471781)
13. Ensoli B, Stürzl M. 1998. Kaposi's sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9:63-83. (Pubitemid 28280537)
14. Ensoli B, Stürzl M, Monini P. 2000. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Semin Cancer Biol 10:367-381.
15. Fiorelli V, Gendelman R, Sirianni MC, Chang HK, Colombini S, Markham PD, Monini P, Sonnabend J, Pintus A, Gallo RC, Ensoli B. 1998. Gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: An immune response to human herpesvirus-8 infection? Blood 91:956-967.
16. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25:217-222. (Pubitemid 30394997)
17. Foster-Cuevas M, Wright GJ, Puklavec MJ, Brown MH, Barclay AN. 2004. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J Virol 78:7667-7676. (Pubitemid 38915913)
18. Ganem D. 2007. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1:273-296.
19. Gorczynski RM. 2005. CD200 and its receptors as targets for immunoregulation. Curr Opin Investig Drugs 6:483-488. (Pubitemid 40613969)
20. Gorczynski RM, Yu K, Clark D. 2000. Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo. J Immunol 165:4854-4860.
21. Jenmalm MC, Cherwinski H, Bowman EP, Phillips JH, Sedgwick JD. 2006. Regulation of myeloid cell function through the CD200 receptor. J Immunol 176:191-199. (Pubitemid 43023263)
22. Lagos D, Trotter MW, Vart RJ, Wang HW, Matthews NC, Hansen A, Flore O, Gotch F, Boshoff C. 2007. Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood 109:1550-1558. (Pubitemid 46239588)
23. Linderoth J, Rambech E, Dictor M. 1999. Dominant human herpesvirus type 8 RNA transcripts in classical and AIDS-related Kaposi's sarcoma. J Pathol 187:582-587. (Pubitemid 29152001)
24. Lubben NB, Sahlender DA, Motley AM, Lehner PJ, Benaroch P, Robinson MS. 2007. HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2. Mol Biol Cell 18:3351-3365. (Pubitemid 47378676)
25. McSharry BP, Burgert HG, Owen DP, Stanton RJ, Prod'homme V, Sester M, Koebernick K, Groh V, Spies T, Cox S, Little AM,Wang EC, Tomasec P, Wilkinson GW. 2008. Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J Virol 82:4585-4594.
26. Minas K, Liversidge J. 2006. Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? Crit Rev Immunol 26:213-230.
27. Monini P, Colombini S, Stürzl M, Goletti D, Cafaro A, Sgadari C, Buttò S, Franco M, Leone P, Fais S, Leone P, Melucci-Vigo G, Chiozzini C, Carlini F, Ascherl G, Cornali E, Zietz C, Ramazzotti E, Ensoli F, Andreoni M, Pezzetti P, Rezza G, Yarchoan R, Gallo RC, Ensoli B. 1999. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93:4044-4058. (Pubitemid 29279246)
28. Nicholas J. 2007. Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia. Front Biosci 12:265-281. (Pubitemid 46860211)
29. Ohmura-Hoshino M, Goto E, Matsuki Y, Aoki M, Mito M, Uematsu M, Hotta H, Ispido S. 2006. A novel family of membrane-bound E3 ubiquitin ligases. J Biochem 140:147-154. (Pubitemid 44618899)
30. Orenstein JM, Alkan S, Blauvelt A, Jeang KT, Weinstein MD, Ganem D, Herndier B. 1997. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11:F35-F45. (Pubitemid 27135875)
31. Pecere T, Sarinella F, Salata C, Gatto B, Bet A, Dalla Vecchia F, Diaspro A, Carli M, Palumbo M, Palù G. 2003. Involvement of p53 in specific anti-neuroectodermal tumor activity of aloeemodin. Int J Cancer 106:836-847. (Pubitemid 37071661)
32. Ramegowda B, Tesh VL. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect Immun 64:1173-1180. (Pubitemid 26102376)
33. Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, Borowski L, Watkins SC, Rinaldo CR, Jr. 2006. DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 176:1741-1749.
34. Rappocciolo G, Hensler HH, Jais M, Reinhart TA, PeguA, Jenkins FJ, Rinaldo CR. 2008. HHV-8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J Virol 82:4793-4806.
35. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2:342-346. (Pubitemid 26080656)
36. Rezaee SA, Gracie JA, McInnes IB, Blackbourn DJ. 2005. Inhibition of neutrophil function by the Kaposi's sarcoma-associated herpesvirus vOX2 protein. AIDS 19:1907-1910. (Pubitemid 41546610)
37. Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ. 2006. Kaposi's sarcoma-associated herpesvirus immune modulation: An overview. J Gen Virol 87:1781-1804. (Pubitemid 43985863)
38. Rijkers ES, de Ruiter T, Baridi A, Veninga H, Hoek RM, Meyaard L. 2008. The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes. Mol Immunol 45:1126-1135. (Pubitemid 350016325)
39. Saito K, Ait-Goughoulte M, Truscott SM, Meyer K, Blazevic A, Abate G, Ray RB, Hoft DF, Ray R. 2008. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol 82:3320-3328.
40. Shiratori I, Yamaguchi M, Suzukawa M, Yamamoto K, Lanier LL, Saito T, Arase H. 2005. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J Immunol 175:4441-4449. (Pubitemid 41361980)
41. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501.
42. Stordeur P, Poulin LF, Craciun L, Zhou L, Schandené L, de Lavareille A, Goriely S, Goldman M. 2002. Cytokine mRNA quantification by real-time PCR. J Immunol Methods 259:55-64. (Pubitemid 33124384)
43. Strack B, Calistri A, Accola MA, Palù G, Gottlinger HG. 2000. A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci USA 97:13063-13068.
44. Valmary S, Richard P, Brousset P. 2005. Frequent detection of Kaposi's sarcoma herpesvirus in germinal centre macrophages from AIDS-related multicentric Castleman's disease. AIDS 19:1229-1231. (Pubitemid 41059266)
45. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, Brown MH, Barclay AN. 2000. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13:233-242.
46. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T, Liu MR, Brown MH, Sedgwick JD, Phillips JH, Barclay AN. 2003. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 171:3034-3046. (Pubitemid 37093527)
47. Yin JL, Shackel NA, Zekry A, McGuinness PH, Richards C, Putten KV, McCaughan GW, Eris JM, Bishop GA. 2001. Real-time reverse transcriptase- polymerase chain reaction (RTPCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol 79:213-221. (Pubitemid 32522168)
48. Zeng L, Yang S, Wu C, Ye L, Lu Y. 2006. Effective transduction of primary mouse blood- and bone marrow-derived monocytes/macrophages by HIV-based defective lentiviral vectors. J Virol Methods 134:66-73.